EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)
| 10.48 Delayed Data As of May 17 |  +0.28 / +2.75%Today’s Change | 7.30 Today|||52-Week Range 21.50 | -14.38% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 26.6M | 1.6M | 7.5M | 3.0M | |
| Depreciation And Amortization | 882.0K | 908.0K | 815.0K | 1.1M | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 19.4M | 22.4M | 24.8M | 28.1M | ||
| Research And Development | 11.4M | 14.3M | 14.4M | 16.2M | ||
| Total Operating Expenses | 20.3M | 23.3M | 25.6M | 29.2M | ||
| Non-Operating Expenses | Operating Income | 6.3M | -21.7M | -18.1M | -26.3M | |
| Extraordinary Charge | 0.00 | -218.0K | -472.0K | -26.3M | ||
| Interest Expense On Debt | 0.00 | 0.00 | 0.00 | 720.0K | ||
| Other Expenses | 3.0K | 72.0K | 91.0K | 101.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 6.3M | -21.9M | -18.5M | -53.2M | |
| Income Taxes | -71.0K | -314.0K | 0.00 | 0.00 | ||
| Net Income | 6.3M | -21.5M | -18.5M | -53.2M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 29.4M | 31.6M | 35.3M | 46.2M | |
| Shares To Calculate EPS Diluted | 30.6M | 31.6M | 35.3M | 46.2M | ||
| Earnings Per Share | EPS | $0.21 | -$0.68 | -$0.52 | -$1.15 | |
| EPS Diluted | $0.21 | -$0.68 | -$0.52 | -$1.15 | ||
